Cargando…
Serum Insulin-Like Growth Factor-1 in Patients with De Novo, Drug Naïve Parkinson’s Disease: A Meta-Analysis
OBJECTIVE: Insulin-like growth factor-1 (IGF-1) is reported to be neuroprotective in the setting of Parkinson’s disease (PD), and there is increasing interest in the possible association of serum IGF-1 levels with PD patients, but with conflicting results. Therefore, we conducted a meta-analysis to...
Autores principales: | Li, Dun-Hui, He, Ya-Chao, Quinn, Thomas J., Liu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684362/ https://www.ncbi.nlm.nih.gov/pubmed/26657015 http://dx.doi.org/10.1371/journal.pone.0144755 |
Ejemplares similares
-
Conditioned pain modulation in drug-naïve patients with de novo Parkinson’s disease
por: Grashorn, Wiebke, et al.
Publicado: (2019) -
Polysomnographic correlates of sleep disturbances in de novo, drug naïve Parkinson’s Disease
por: Orso, Beatrice, et al.
Publicado: (2021) -
Psychiatric profile of motor subtypes of de novo drug‐naïve Parkinson's disease patients
por: Assogna, Francesca, et al.
Publicado: (2018) -
Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
por: Boertien, Jeffrey M., et al.
Publicado: (2022) -
Characterizing white matter alterations subject to clinical laterality in drug‐naïve de novo Parkinson's disease
por: Xiao, Yiming, et al.
Publicado: (2021)